Tuesday, February 19, 2019
The Clean Facility of the Future documentary explores issues surrounding establishment and maintenance of clean facilities for biopharmaceutical reserach through discussions with thought leaders. In this round table series, we ask these thought leaders to expand on topics presented in the documentary. In this fourth roundtable discussion, key stakeholders were asked:
What are some best practices a pharmaceutical company should put in place to collect, store and analyze microbial monitoring data?
Check back to our first roundtable to read about must-have technologies for meeting microbial monitoring requirements, our second roundtable for a discussion on first steps a pharmaceutical company can take to upgrade microbial monitoring, and our third roundtable for a discussion on whether pharmaceutical companies are likely to implement the same strict mircoial monitoring strategies used for sterile products on other types of products.